Current management of cutaneous malignant melanoma of the head and neck

Acta Oto-Laryngologica

Volumn 122, Issue 8, 2002, Pages 900-906

  Medina, Jesus E ^a   Ferlito, Alfio ^b,l   Brandwein, Margaret S ^c   Fisher, Samuel R ^d   Pellitteri, Phillip K ^e   Shaha, Ashok R ^f   Pitman, Karen T ^g   Robbins, K Thomas ^h   Rinaldo, Alessandra ^b   Silver, Carl E ⁱ   Byers, Robert M ^j   O'Brien, Christopher J ^k  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF UDINE   (Italy)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e GEISINGER MEDICAL CENTER   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^l UNIVERSITY HOSPITAL OF UDINE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ESTHETIC SURGERY; FROZEN SECTION; HEAD CANCER; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MEDICAL SOCIETY; MELANOMA; NECK CANCER; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCINTIANGIOGRAPHY; SENTINEL LYMPH NODE; SKIN CANCER; SKIN GRAFT; SURGICAL TECHNIQUE;

HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MELANOMA; SKIN NEOPLASMS;

EID: 0036968801     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000028067     Document Type: Review

References (29)

1. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-48.
2. Veronesi U, cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988; 318: 1159-62.
3. National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma. Am J Dermatopathol 1993; 15: 34-43.
4. Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993; 218: 262-7.
5. Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol 1997; 37: 422-9.
6. Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000; 26: 771-84.
7. Ang KK, Byers RM, Peters LJ, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otoaryngol Head Neck Surg 1990; 116: 169-72.
8. Berman CG, Norman J, Cruse CW, Reintgen DS, Clark RA. Lymphoscintigraphy in malignant melan-oma. Ann Plast Surg 1992; 28: 29-32.
9. Wanebo HJ, Chung M. Radionuclide lymphoscintigraphy to identify lymphatic drainage patterns of cutaneous head and neck melanoma. Diagn Oncol 1993; 3: 258-62.
10. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastastic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995; 170: 461-6.
11. Essner R, Rose DM, Wanek L, Morton DL. Natural history of early-stage melanoma of the head and neck in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy. Proc 5th Int Conf Head Neck Cancer, San Francisco, CA, 2000: 148.
12. Eicher SA, Clayman GL, Myers JN, Gillenwater AM. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg 2002; 128: 241-6.
13. Jansen L, Koops HS, Nieweg OE, et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck 2000; 22: 27-33.
14. Wagner JD, Park HM, Coleman JJ 3rd, Love C, Hayes JT. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg 2000; 126: 313-21.
15. Ross GL, Shoaib T, Gray HW, et al. The importance of lymphoscintigraphy for sentinel node biopsy for cutaneous melanoma of the head and neck. Nucl Med Commun 2002; 23: 291.
16. Veronesi U, Adamus J, Bandiera DC, et al. Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori 1980; 66: 373-96.
17. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 1978; 41: 948-56.
18. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224: 255-63.
19. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO MM Programme. Lancet 1998; 351: 793-6.
20. Fisher SR. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998. Laryngoscope 2002; 112: 99-110.
21. Kirkwood JM, Ibrahim JG, Sondak VK, et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 2000; 18: 2444-58.
22. Hauschild A, Glaser R, Christophers E. Quantification of melanoma-associated molecules in plasma/serum of melanoma patients. Recent Results Cancer Res 2001; 158: 169-77.
23. Djukanovic D, Hofmann U, Sucker A, Rittgen W, Schadendorf D. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma. Anticancer Res 2000; 20: 2203-7.
24. Bosserhoff AK, Dreau D, Hein R, Landthaler M, Holder WD, Buettner R. Melanoma inhibitory activity (MIA), a serological marker of malignant melanoma. Recent Results Cancer Res 2001; 158: 158-68.
25. Pathak I, O'Brien CJ, Petersen-Schaeffer K, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck 2001; 23: 785-90.
26. O'Brien CJ, Petersen-Schaefer K, Ruark D, Coates AS, Menzie SJ, Harrison RI. Radical, modified, and selective neck dissection for cutaneous malignant melanoma. Head Neck 1995; 17: 232-41.
27. Singletary SE, Byers RM, Shallenberger R, McBride CM, Guinee VF. Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. Am J Surg 1986; 152: 371-5.
28. O'Brien CJ, Petersen-Schaefer K, Stevens GN, et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 1997; 19: 589-94.
29. Shen P, Wanek LA, Morton DL. Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas? Ann Surg Oncol 2000; 7: 554-9.